Skip to content

Charles River Laboratories CRL Corporate Non — Transaction Costs

Discontinued — last reported Q1 '18

Similar metrics at other companies

AT&T logo
TCorporate & Other — Transaction, legal and other costs
$146M+84.8%
Apollo Global Management logo
APOAsset Management — Transaction-related costs, restructuring and other non-operating expenses
-$69M+75.0%
Loar Holdings logo
LOARTransaction Expenses
$1.24M+169%
KKR & Co. logo
KKRAsset Management and Insurance Segments — Transaction-related costs and other corporate actions
$30M
NRG Energy logo
NRGAcquisition-related transaction and integration costs
$45M+463%
CareTrust logo
CTRETransaction costs
$207K-76.7%

Other financials

Income statement

See full
Revenue$995.8M+1.2%
Gross profit$349.0M-3.5%
Operating income$119.9M+60.6%
Net income-$14.8M-158%
EPS (diluted)-$0.30-160%

Balance sheet

See full
Cash & equivalents$198.2M-14.5%
Total debt$3.1B+1.9%
Total equity$2.9B-7.9%
Total assets$7.7B+2.0%

Cash flow

See full
Operating cash flow$41.1M-76.1%
CapEx$55.9M-5.8%
Free cash flow-$14.8M-113%

Valuation

See full
Market cap$8.91B+10.3%
Enterprise value$11.79B+8.5%
P/S2.2×+0.2×

Profitability

See full
Gross margin84.7%
Operating margin13%-2.4pp
Net margin-4.6%
FCF margin9.7%-4.3pp

Returns & leverage

See full
Return on equity-6%
Debt / equity+0.1×
Current ratio1.4×-0.1×

Where this comes from

Reported directly by Charles River Laboratories in its filing.

Tagged under the XBRL concept crl:TransactionCosts.

The official record: Charles River Laboratories’s 10-Q, filed May 10, 2018, on SEC EDGAR. View the filing →

Questions, answered.

What does corporate non — transaction costs mean?
Includes non-recurring expenses directly related to corporate development activities, such as mergers, acquisitions, and divestitures. These costs typically cover legal, advisory, and integration-related fees incurred during inorganic growth initiatives.